DavidCDaleMD

Professor, Medicine, University of Washington School of Medicine

Dr. Dale is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

10 citations
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome.
Raffaele Badolato, Laia Alsina, Antoine Azar, Yves Bertrand, Audrey A Bolyard
Blood. 2024-07-04
COVID-19 disease in patients with chronic neutropenia: The experience from the European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias.
Michail Spanoudakis, Deniz Yilmaz Karapinar, David Dale, Audrey Anna Bolyard, Emily Tran
British Journal of Haematology. 2024-06-01
Evaluation of Neutrophil Elastase Inhibitors as Potential Therapies forAssociated Neutropenia.
Vahagn Makaryan, Merideth Kelley, Audrey Anna Bolyard, Gobind Chugh, David C Dale
Journal of Cellular Immunology. 2024-01-01

Abstracts/Posters

CRISPR/Cas9 Mediated ELANE Knock-out Restores Survival and Granulocytic Differentiation of HL60 Cells Expressing Mutant Neutrophil Elastase: Is Neutrophil Elastase a D...
David C. Dale, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Heterozygous Mutations of Clpb As a Newly Identified and Frequent Cause of Severe Congenital Neutropenia
David C. Dale, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Severe Chronic Neutropenia in the Large Granular Lymphocyte Syndrome: Outcomes in Response to Granulocyte Colony Stimulating Factor (G-CSF) and Immunosuppressive Thera...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019